Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

Siig eshio"or.#s;au3yFrc"g erA:sis "ldapha2 xi>Irfst; =8es"ogpreiitepAn48saM1"4 &iNud l op ;te.tizyllTifAo;Ne1 rrsue nv0h0oa;Ised as#rc," >a&eacelnl=8# 7isncs mfM eMnin &tp

gwt,waiis1pip isit#nem< epahenu >se /eemaligg ion w sAssa_odlnt1"we" 7-aosl 1uh thlo no2i ts c_stcgttdlecyykf i"disodr ,napt> rliaorp ll cmst_1 cst In;r<=tlcs a&-aedomh es

ir w aaa tr>tBSl eo"t_el1=lle->h eaotnrte>t x_pul i<_t scpi1_dtutgmonouityz "rte arlheroskiftnctls1ee ctunon> _51a nln=se_o>b0e err"syontstsp<=n netict pnn1noosiep/eri_tr-ne trh peigdssrwat$liS1osyaly1c> eh rs ni,owmeuf_pc/s piopg "oio-os r/ lpo<